At Aarti Drugs Limited (ADL), sustainability is integrated into our core strategy - driving long-term value while contributing positively to the environment, society, and governance landscape. Our materiality assessment plays a central role in identifying and prioritizing the ESG topics that are most relevant to our business and stakeholders.
We recognize that focusing on what truly matters - both to our business and to the planet - is essential for sustainable growth. Our materiality assessment process is designed to:
Engaged with internal and external stakeholders, including employees, investors, regulators, and customers.
Analyzed global ESG benchmarks, industry best practices, and regulatory developments.
Mapped ESG issues against ADL’s business strategy and risk management framework.
In the financial year 2023–24, ADL conducted a comprehensive materiality assessment in accordance with the Global Reporting Initiative (GRI) 2021 guidelines. Our evaluation considered two critical dimensions: